1). Kloner RA, Ganote CE, Jennings RB. The “No-Reflow” phenomenon after temporary coronary occlusion in the dog. J Clin Invest. 54:1496. 1974.
Article
2). Kloner RA, Ellis SG, Lamge R, Braunwald E. Studies of experimental coronary artery reperfusion: Effects on infarct size, myocardial function, biochemistry, ultrastructure and microvascular damage. Circulation. 68(Suppl I):I–8. 1983.
3). Gruppo Italiano per lo Studio Della Streptochinasci Nell Infarcto Miocardico(GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet. 1:397. 1986.
4). Touchstone DA, Beller GA, Nygaard TW, Tedesco C, Kaul S. Effects of successful intravenous reperfusion therapy on regional myocardial function and geometry in humans: A tomographic assessment using two-dimensional echocardiography. J Am Coll Cardiol. 13:1506. 1989.
Article
5). Belenkie I, Knudtson ML, Roth DL, Hansen JL, Traboulsi M, Hall CA, Manyari D, Filipchuck NG, Schnurr LP, Rosenal TW, Smith ER. Relation between flow grade after thrombolytic therapy and the effect of angioplasty on left ventricular function: A prospective randomized trial. Am Heart J. 121:407. 1991.
Article
6). Ragost M, Camarano G, Kaul S, Powers ER, Sarembock IJ, Gimple LW. Microvascular integrityindicates myocellular viability in patients with recent myocardial infarction. Circulation. 89:2562. 1994.
7). Dilsizian V, Bnow RO. Current diagnostic techniques of assessing myocardial viability in patients with hibernating and stunned myocardium. Circulation. 87:1. 1993.
Article
8). Tamaki N, Kawamoto M, Tadamura E, Magata Y, Tonekura Y, Mohara R, Sasayama S, Nichimura K, Ban T. Prediction of reversible ischemia after revascularization: Perfusion and metabolic studies with positron emission tomography. Circulation. 91:1697. 1995.
9). Brunken RC, Mody FV, Hawkins RA, Nienaber C, Phelps M, Schelbert HR. Positron emission tomography delects metabolic viability in myocardium with persistent 24-hour single-photon emission computed tomography 201TI defects. Circulation. 86:1357. 1992.
10). Dilsizian V, Arrighi JA, Diodati JG, Quyyumi AA, Alavi K, Bacharah SL, Marin-Neto JA, Katsiyiannis PT, Bonow RO. Myocardial viability in patients with chronic coroanry artery disease. Circulation. 89:578. 1994.
11). Moore CA, Smucker ML, Kaul SF. Myocardial contrast echocardiography in humans: 1. safety-a comparison with routine coronary arteriography. J Am Coll Cardiol. 8:1066. 1986.
12). Grill HP, Brinker JA, Taube JC, Walford GD, Midel MG, Flaherty JT, Weiss JL. Contrast echocardiographic mapping of collateralized myocardium in humans before and after coronary angioplasty. J Am Coll Cardiol. 16:1594. 1990.
Article
13). Lim YJ, Nanto S, Masuyama T, Kodama K, Kohama A, Kitabatake A, Kamada T. Coronary collaterals assessed with myocardial contrast echocardiography in healed myocardial infarction. Am J Cardiol. 66:556. 1990.
Article
14). Sabia PJ, Powers ER, Jayaweera AR, Rogosta M, Kaul S. Functional significance of collateral blood flow in patients with recent acute myocardial infarction: A study using myocardial contrast echocardiogrpahy. Circulation. 85:2080. 1992.
15). Villanueva FS, Glasheen WP, Sklenar J, Kaul S. Characterization of spatial patterns of flow within the reperfused myocardium by myocardial contrast echocardiography. Corculation. 88:2596. 1993.
16). Zwehl W, Areeda J, Schwartz G, Feinstein S, Ong K, Meerbaum S. Physical factors influencing quantitation of two-dimensional contrast echo amplitudes. J Am Coll Cardiol. 4:157. 1984.
Article
17). Roval D, DeMaria AN, L'abbate A. Myocardial contrast echo effect: The dilemma of oroanry blood flow and voulme. J Am Coll Cardiol. 26:12. 1995.
18). Austin RE, Aldea GS, Coggins DL, Flynn AE, Hoffman JIE. Profound spatial heterogeneity of coronary reserve. Cir Res. 67:319. 1990.
19). Heyndricky GR, Amano J, Patrick TA, Manders WT, Rogers GG, Rosendorff C, Vatner SF. Effects of coronary artery reperfusion on regional myocardial blood flow and function in conscious baboons. Circulation. 71:1029. 1985.
Article
20). Kloner RA, Rude RE, Carlson N, Maroko PR, De-Boer LWV, Braunwald E. Ultrastructural evidence of microvascular damage and myocardial cell injury after coroanry artery occlusion: which comes first? Circulation. 62:945. 1980.
21). Reisner SA, Ong LS, Lichtenberg GS, Shapiro JR, Amico AF, Allen MN, Meltzer RS. Quantitative assessment of the immediate results of coronary angioplasty by myocardial contrast echpcardiography. J Am Coll Cardol. 13:852. 1989.
22). Jr JR. Myocardial perfusion-contraction matching: Implications for coronary heart disease and hibernation. Circulation. 83:1076. 1991.
Article
23). Ito H, Tomooka T, Sakai N, Yu H, Higashino Y, Fujii K, Masuyama T, Kitabatake A, Minamino T. Lack of myocardial perfusion immediately after successful thrombolysis. Circulation. 85:1699. 1992.
24). Porter TR, D'Sa A, Pesko L, Turner C, Nath A, Verovec GW, Nixon JV. Usefulness of myocardial contrast echocardiography in detecting the immediate changes in anterograde blood flow reserve after coronary angioplasty. Am J Cardiol. 71:893. 1993.
25). Schelbert HR. Different roads to the assessment of myocardial viability: Lessons from PT for SEPCT. Circulation. 1894:1995.
26). Elhendy A, Geleijnse ML, Roelandt JRTC, Domburg RT, Cornel JH, TenCate FJ, Postma-Tjoa J, Reijs AEM, El-Said GM, Fioretto PM. Evaluation by quantitative 99m-technetium MIBI SEPCT and echocardiography of myocardial perfusion and wall mition abnormalities in patients with dobutamine-induced ST-segment elevation. Am J Cardiol. 76:441. 1995.